Analysts Swing to Diverse Views for Exact Sciences Corporation (EXAS), Abercrombie & Fitch Co. (ANF)

Shares of Exact Sciences Corporation (NASDAQ:EXAS) opened at $49.35, and ended -0.46% lower at $49.84. Nearly 1.95 million shares were traded by the close, lower than its average daily volume of 2.41 million shares.

Exact Sciences Corporation (EXAS) Analyst Opinion

Exact Sciences Corporation has a consensus outperform rating from 13 Wall Street analysts, and the number of shares currently sold short amount to at least 8.26% of shares outstanding. The stock sank -6.17% last month and is down -5.14 this year. Wall Street is only getting more bullish on the stock, with 8 of analysts who cover EXAS having a buy-equivalent rating. Analysts have placed a $59.6 price target on Exact Sciences Corporation, suggesting a 19.58% gain from recent close. It’s currently trading about -21.64% below its 52-week high.

Exact Sciences Corporation Earnings Surprise

Exact Sciences Corporation (EXAS) revenue totaled $65.01 million up 12.77% from the previous quarter.

Exact Sciences Corporation (NASDAQ:EXAS) Intraday View

This stock (EXAS) is ahead of its 52-week low with 181.58%. Its last month’s stock price volatility remained 5.36% which for the week stands at 6.06%. The share price has moved backward from its 20 days moving average, trading at a distance of -4.37% and stays -7.85% away from its 50 days moving average. Over the last five days, shares have managed 2.78% gains and now is up 15.63% since hitting its 200-day moving average of $48.01. Exact Sciences Corporation (EXAS) has made its way to a 12-month gain of 171.61%.

Turning to Abercrombie & Fitch Co. (NYSE:ANF), its shares were trading at $21.87 a retreat of $-0.34, on the trading floor. The stock, after opening at $22.05, touched a high of $22.44 before paring much of its gains. So far, analysts are sticking with their bearish recommendations with the consensus call at 3. Abercrombie & Fitch Co. has 3 buy ratings, 8 holds and 3 sells even after the stock tumbled -7.05% from its high of $23.53 to a $1.5 billion market value through last close.

Abercrombie & Fitch Co. (ANF) Consensus Price Target

The company’s consensus rating on Reuter’s scale slipped from 3.29 to 3.18 during a month. Analysts set a 12-month price target of $19.38 a share. The target implies a -11.39% decrease from where the shares are currently trading. Also, the current price highlights a discount of 32.6% to analysts’ high consensus price target.

Abercrombie & Fitch Co. (NYSE:ANF) Intraday Trading

The counter witnessed a trading volume of 1.63 million shares versus an average volume of 3.06 million shares during last trading session. Its last month’s stock price volatility remained 5.33% which for the week approaches 4.64%. The lowest price the stock reached in the last trading day was $21.68 and compares with the $8.81 52-week low. The stock recovered 148.24% since its low point and has performed 25.47% year-to-date.

Previous articleAnalyst Opinion On How To Bet On Tronox Limited (TROX), Uranium Energy Corp. (UEC)
Next articleVaried Analyst Comments On Keryx Biopharmaceuticals, Inc. (KERX), ACADIA Pharmaceuticals Inc. (ACAD)